ArticleMedical physics2026
Machine Model-Specific Delivery Sequence Optimization for Spot-scanning Proton Arc Therapy Using a Compact Superconducting Synchrocyclotron.
Article in Medical physics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundSpot scanning proton arc therapy (SPArc) combines the dosimetric advantages of proton therapy with the beam-angle freedom of arc delivery. However, current planning algorithms rely on static delivery assumptions that do not account for the temporal characteristics of pulsed-beam synchrocyclotron systems during continuous gantry rotation. This mismatch between nominal plans and actual treatment delivery may lead to clinically meaningful dose deviations. PURPOSE: To develop and evaluate a dynamic arc delivery sequencing optimization framework that incorporates machine-specific delivery characteristics to minimize deviations between planned and delivered dose in SPArc.
methodsA five-step dynamic arc delivery sequencing optimization framework was developed. The framework includes: (1) static and dynamic delivery time calculation, (2) spot and energy-layer disassembling, (3) incorporation of dynamic delivery timing into control points, (4) spot-weight fine-tuning, and (5) reconstruction of energy-layer sequences. Five multi-metastatic brain stereotactic radiosurgery cases were retrospectively evaluated. Delivery accuracy, efficiency and plan quality were assessed using virtual machine logfiles.
resultsThe sequencing optimization framework substantially improved delivery accuracy while preserving plan quality and efficiency. For the total gross tumor volume, the mean absolute D98 deviation between planned and virtual logfile reconstructed doses decreased from 77.4 ± 81.0 cGyE (4.2 ± 4.5%) with static SPArc plans to 9.6 ± 4.0 cGyE (0.5 ± 0.2%) after sequencing optimization. For the worst metastasis in each case, D98 deviation decreased from 184.4 ± 145.2 cGyE (9.8 ± 7.9%) to 19.0 ± 16.4 cGyE (1.0 ± 0.8%), and D2 deviation decreased from 148.4 ± 114.4 cGyE (6.8 ± 5.6%) to 13.2 ± 8.6 cGyE (0.6 ± 0.4%). Target coverage and normal brain sparing remained statistically unchanged (p > 0.05), and total delivery times differed by < 1 s.
conclusionsThe proposed sequencing optimization framework addresses the temporal mismatch between static SPArc planning and dynamic delivery in synchrocyclotron-based systems. By improving delivery accuracy without compromising plan quality or delivery efficiency, the framework demonstrates the feasibility of incorporating machine-specific delivery timing into dynamic proton arc therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.